Novo Nordisk, which manufactures the popular weight-loss drug Wegovy, earlier this year paid $11 billion for three fill-finish manufacturing sites that in part will help ramp up its production of drugs to treat obesity and diabetes
Without estrogen, GLP-1 therapy may partially stand in to maintain vascular resilience
GLP-1 suppresses appetite broadly, but users who are eating less tend to prioritize nutrient density when they do eat
[20] Musculoskeletal discomfort (myalgia, limb pain) usually surfaces 12-24 hours after dosing, peaks at 48 hours, and resolves within 72 hours
Injection Technique Clean vial stopper and skin with alcohol
In some embodiments, an otoendoscope (e.g., about 1.7 mm in diameter) is used to visualize the round window membrane